Oncologic and fertility outcomes in patients with juvenile granulosa cell tumor - a retrospective single centre analysis

IF 4.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY
Giuseppe Marino , Liliana Marchetta , Serena Negri , Filippo Testa , Daniele Lugotti , Giulia Cavallo , Tommaso Grassi , Marta Jaconi , Elena De Ponti , Maria Cristina Bonazzi , Fabio Landoni , Robert Fruscio
{"title":"Oncologic and fertility outcomes in patients with juvenile granulosa cell tumor - a retrospective single centre analysis","authors":"Giuseppe Marino ,&nbsp;Liliana Marchetta ,&nbsp;Serena Negri ,&nbsp;Filippo Testa ,&nbsp;Daniele Lugotti ,&nbsp;Giulia Cavallo ,&nbsp;Tommaso Grassi ,&nbsp;Marta Jaconi ,&nbsp;Elena De Ponti ,&nbsp;Maria Cristina Bonazzi ,&nbsp;Fabio Landoni ,&nbsp;Robert Fruscio","doi":"10.1016/j.ygyno.2024.11.007","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Granulosa cell tumors (GCTs) are rare neoplasia that account for less than 5 % of all the ovarian tumors. Juvenile GCT histotype is generally observed in adolescent and young women, representing a very rare disease, so only a paucity of data are present in literature. The aim of this study is to analyse the oncologic and fertility outcome in our case series of juvenile GCTs.</div></div><div><h3>Methods</h3><div>Clinicopathological data were retrospectively collected and analysed from a cohort of 30 patients ovarian juvenile GCTs treated at IRCCS San Gerardo dei Tintori Hospital, Monza, between 1980 and 2024.</div></div><div><h3>Results</h3><div>The median age of disease onset was 21.5. Among patients enrolled in the study, 80.0 % (24/30) were stage I (16/26, 1/26 and 7/26 of stage IA, IB and IC, respectively), 6.7 % (2/30) were stage II and 13.3 % stage III (4/30). In 86.7 % (26/30) of patients, a fertility-sparing surgery was carried out, while 13.3.% (4/30) of patients underwent radical surgery. Adjuvant chemotherapy was administered in 20.0 % (6/30) of cases, while 80.0 % (24/30) were followed only with surveillance. Three patients in thirty (10.0 %) relapsed and died of disease despite multi-therapeutic approaches. All of them had advanced stages of disease at time of diagnosis.</div></div><div><h3>Conclusions</h3><div>Juvenile GCT appears to have a good prognosis at stage I disease. However, advanced stage represents a hard challenge for clinicians, showing a high rate of relapse and mortality.</div></div>","PeriodicalId":12853,"journal":{"name":"Gynecologic oncology","volume":"192 ","pages":"Pages 89-93"},"PeriodicalIF":4.5000,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecologic oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0090825824012046","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Granulosa cell tumors (GCTs) are rare neoplasia that account for less than 5 % of all the ovarian tumors. Juvenile GCT histotype is generally observed in adolescent and young women, representing a very rare disease, so only a paucity of data are present in literature. The aim of this study is to analyse the oncologic and fertility outcome in our case series of juvenile GCTs.

Methods

Clinicopathological data were retrospectively collected and analysed from a cohort of 30 patients ovarian juvenile GCTs treated at IRCCS San Gerardo dei Tintori Hospital, Monza, between 1980 and 2024.

Results

The median age of disease onset was 21.5. Among patients enrolled in the study, 80.0 % (24/30) were stage I (16/26, 1/26 and 7/26 of stage IA, IB and IC, respectively), 6.7 % (2/30) were stage II and 13.3 % stage III (4/30). In 86.7 % (26/30) of patients, a fertility-sparing surgery was carried out, while 13.3.% (4/30) of patients underwent radical surgery. Adjuvant chemotherapy was administered in 20.0 % (6/30) of cases, while 80.0 % (24/30) were followed only with surveillance. Three patients in thirty (10.0 %) relapsed and died of disease despite multi-therapeutic approaches. All of them had advanced stages of disease at time of diagnosis.

Conclusions

Juvenile GCT appears to have a good prognosis at stage I disease. However, advanced stage represents a hard challenge for clinicians, showing a high rate of relapse and mortality.
幼年颗粒细胞瘤患者的肿瘤学和生育结局--一项单一中心的回顾性分析。
背景:颗粒细胞瘤(GCT)是一种罕见的肿瘤,在所有卵巢肿瘤中所占比例不到 5%。幼年GCT组织型通常见于青少年和年轻女性,是一种非常罕见的疾病,因此文献中的数据非常少。本研究旨在分析我们的幼年GCT病例系列中的肿瘤学和生育结局:方法:回顾性收集并分析了1980年至2024年间在蒙扎圣杰拉尔多丁托里IRCCS医院接受治疗的30例卵巢幼年型GCT患者的临床病理数据:结果:发病年龄中位数为 21.5 岁。参与研究的患者中,80.0%(24/30)为I期(IA、IB和IC期分别为16/26、1/26和7/26),6.7%(2/30)为II期,13.3%为III期(4/30)。86.7%的患者(26/30)接受了保胎手术,13.3%的患者(4/30)接受了根治手术。20.0%的患者(6/30)接受了辅助化疗,80.0%的患者(24/30)只接受了监测。30例患者中有3例(10.0%)尽管采用了多种治疗方法,但病情还是复发并死亡。这些患者在确诊时都已是晚期:青少年 GCT 在疾病 I 期时似乎预后良好。然而,晚期对临床医生来说是一项艰巨的挑战,复发率和死亡率都很高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Gynecologic oncology
Gynecologic oncology 医学-妇产科学
CiteScore
8.60
自引率
6.40%
发文量
1062
审稿时长
37 days
期刊介绍: Gynecologic Oncology, an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Investigations relating to the etiology, diagnosis, and treatment of female cancers, as well as research from any of the disciplines related to this field of interest, are published. Research Areas Include: • Cell and molecular biology • Chemotherapy • Cytology • Endocrinology • Epidemiology • Genetics • Gynecologic surgery • Immunology • Pathology • Radiotherapy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信